Myelodysplastic syndrome: etiology, natural history, current and future therapies
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2004
|
| Schriftenreihe: | Best practice & research
Clinical haematology ; 17,4 |
| Schlagworte: | |
| Beschreibung: | S. 535 - 661, III S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV019587468 | ||
| 003 | DE-604 | ||
| 005 | 20041126 | ||
| 007 | t | ||
| 008 | 041115s2004 |||| 00||| eng d | ||
| 035 | |a (OCoLC)58470135 | ||
| 035 | |a (DE-599)BVBBV019587468 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-578 | ||
| 245 | 1 | 0 | |a Myelodysplastic syndrome |b etiology, natural history, current and future therapies |c Jacob M. Rowe guest ed. |
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2004 | |
| 300 | |a S. 535 - 661, III S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Best practice & research : Clinical haematology |v 17,4 | |
| 650 | 7 | |a Myelodysplastische syndromen |2 gtt | |
| 650 | 4 | |a Myelodysplastic Syndromes | |
| 650 | 4 | |a Myelodysplastic Syndromes |x trends | |
| 700 | 1 | |a Rowe, Jacob M. |e Sonstige |0 (DE-588)1038024552 |4 oth | |
| 830 | 0 | |a Best practice & research |v Clinical haematology ; 17,4 |w (DE-604)BV013685162 |9 17,4 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012924305 | ||
Datensatz im Suchindex
| _version_ | 1804132946415714304 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)1038024552 |
| building | Verbundindex |
| bvnumber | BV019587468 |
| ctrlnum | (OCoLC)58470135 (DE-599)BVBBV019587468 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01049nam a2200301 cb4500</leader><controlfield tag="001">BV019587468</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20041126 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041115s2004 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)58470135</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019587468</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Myelodysplastic syndrome</subfield><subfield code="b">etiology, natural history, current and future therapies</subfield><subfield code="c">Jacob M. Rowe guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 535 - 661, III S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Best practice & research : Clinical haematology</subfield><subfield code="v">17,4</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Myelodysplastische syndromen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myelodysplastic Syndromes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myelodysplastic Syndromes</subfield><subfield code="x">trends</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowe, Jacob M.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1038024552</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Best practice & research</subfield><subfield code="v">Clinical haematology ; 17,4</subfield><subfield code="w">(DE-604)BV013685162</subfield><subfield code="9">17,4</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012924305</subfield></datafield></record></collection> |
| id | DE-604.BV019587468 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T20:00:54Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012924305 |
| oclc_num | 58470135 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-578 |
| owner_facet | DE-19 DE-BY-UBM DE-578 |
| physical | S. 535 - 661, III S. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Elsevier |
| record_format | marc |
| series | Best practice & research |
| series2 | Best practice & research : Clinical haematology |
| spelling | Myelodysplastic syndrome etiology, natural history, current and future therapies Jacob M. Rowe guest ed. Amsterdam [u.a.] Elsevier 2004 S. 535 - 661, III S. txt rdacontent n rdamedia nc rdacarrier Best practice & research : Clinical haematology 17,4 Myelodysplastische syndromen gtt Myelodysplastic Syndromes Myelodysplastic Syndromes trends Rowe, Jacob M. Sonstige (DE-588)1038024552 oth Best practice & research Clinical haematology ; 17,4 (DE-604)BV013685162 17,4 |
| spellingShingle | Myelodysplastic syndrome etiology, natural history, current and future therapies Best practice & research Myelodysplastische syndromen gtt Myelodysplastic Syndromes Myelodysplastic Syndromes trends |
| title | Myelodysplastic syndrome etiology, natural history, current and future therapies |
| title_auth | Myelodysplastic syndrome etiology, natural history, current and future therapies |
| title_exact_search | Myelodysplastic syndrome etiology, natural history, current and future therapies |
| title_full | Myelodysplastic syndrome etiology, natural history, current and future therapies Jacob M. Rowe guest ed. |
| title_fullStr | Myelodysplastic syndrome etiology, natural history, current and future therapies Jacob M. Rowe guest ed. |
| title_full_unstemmed | Myelodysplastic syndrome etiology, natural history, current and future therapies Jacob M. Rowe guest ed. |
| title_short | Myelodysplastic syndrome |
| title_sort | myelodysplastic syndrome etiology natural history current and future therapies |
| title_sub | etiology, natural history, current and future therapies |
| topic | Myelodysplastische syndromen gtt Myelodysplastic Syndromes Myelodysplastic Syndromes trends |
| topic_facet | Myelodysplastische syndromen Myelodysplastic Syndromes Myelodysplastic Syndromes trends |
| volume_link | (DE-604)BV013685162 |
| work_keys_str_mv | AT rowejacobm myelodysplasticsyndromeetiologynaturalhistorycurrentandfuturetherapies |